Literature DB >> 23079729

A patient with simultaneously appearing adenocarcinoma and small-cell lung carcinoma harbouring an identical EGFR exon 19 mutation.

S van Riel, E Thunnissen, D Heideman, E F Smit, B Biesma.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23079729     DOI: 10.1093/annonc/mds525

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  16 in total

Review 1.  Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin.

Authors:  Matthew G Oser; Matthew J Niederst; Lecia V Sequist; Jeffrey A Engelman
Journal:  Lancet Oncol       Date:  2015-04       Impact factor: 41.316

Review 2.  KRAS: A Druggable Target in Colon Cancer Patients.

Authors:  Francesca Negri; Lorena Bottarelli; Gian Luigi de'Angelis; Letizia Gnetti
Journal:  Int J Mol Sci       Date:  2022-04-08       Impact factor: 6.208

Review 3.  Histological transformation after acquired resistance to epidermal growth factor tyrosine kinase inhibitors.

Authors:  Yi Shao; Dian-Sheng Zhong
Journal:  Int J Clin Oncol       Date:  2017-11-07       Impact factor: 3.402

Review 4.  Prognostic and predictive biomarkers in lung cancer. A review.

Authors:  Erik Thunnissen; Kimberly van der Oord; Michael den Bakker
Journal:  Virchows Arch       Date:  2014-01-14       Impact factor: 4.064

5.  Histologic transformation of non-small-cell lung cancer in brain metastases.

Authors:  Meng Jiang; Xiaolong Zhu; Xiao Han; Haiyan Jing; Tao Han; Qiang Li; Xiao Ding
Journal:  Int J Clin Oncol       Date:  2018-11-16       Impact factor: 3.402

Review 6.  Epidermal growth factor receptor (EGFR) mutations in small cell lung cancers: Two cases and a review of the literature.

Authors:  Bradford J Siegele; Konstantin Shilo; Bo H Chao; David P Carbone; Weiqiang Zhao; Olga Ioffe; Wilbur A Franklin; Martin J Edelman; Dara L Aisner
Journal:  Lung Cancer       Date:  2016-02-26       Impact factor: 5.705

7.  Transformation to Small Cell Lung Cancer of Pulmonary Adenocarcinoma: Clinicopathologic Analysis of Six Cases.

Authors:  Soomin Ahn; Soo Hyun Hwang; Joungho Han; Yoon-La Choi; Se-Hoon Lee; Jin Seok Ahn; Keunchil Park; Myung-Ju Ahn; Woong-Yang Park
Journal:  J Pathol Transl Med       Date:  2016-05-10

Review 8.  Small-Cell Lung Cancer Transformation in Patients With Pulmonary Adenocarcinoma: A Case Report and Review of Literature.

Authors:  Shi-Yu Jiang; Jing Zhao; Meng-Zhao Wang; Zhen Huo; Jing Zhang; Wei Zhong; Yan Xu
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

9.  Genetic alterations and protein expression in combined small cell lung cancers and small cell lung cancers arising from lung adenocarcinomas after therapy with tyrosine kinase inhibitors.

Authors:  Xiaohua Shi; Huanli Duan; Xuguang Liu; Liangrui Zhou; Zhiyong Liang
Journal:  Oncotarget       Date:  2016-06-07

Review 10.  [Advances in the Transformation to Small Cell Lung Cancer from Non-small Cell Lung Cancer Following Acquired Drug-resistance to EGFR Tyrosine Kinase Inhibitors].

Authors:  Wenqiu Zhang; Yongqi Li; Di Wu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2017-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.